Much has been written this year related to how the ongoing COVID-19 pandemic has impacted medical device companies, including business disruptions, product shortages, and other challenges. Cybersecurity, though less discussed, is another key risk that can present similar challenges for medical device manufacturers. Companies must focus both on the risk to their medical device products
Robert W. Leung
Robert Leung is Co-Global Vice Chair of the Paul Hastings Corporate Practice and a partner in the firm’s Mergers & Acquisition and Private Equity practices and is based in the firm’s New York office. Mr. Leung has advised an array of clients (corporations, financial institutions, private investment funds, and family offices) on both domestic and cross-border (primarily in Latin America) M&A, private equity, and financing transactions. He has particular experience advising clients in the energy, natural resources, infrastructure, and retail industries.